Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABBA: Antibiotics Dosage in Broncho-Alveolar Lavage
NCT03927079Active, not recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Apr 2019
- Primary completion
- Apr 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial in pneumonia and respiratory tract infection (RTI), sponsored by CHU Amiens-Picardie. Primary endpoint: Pulmonary diffusion level for beta lactamins. Started Apr 2019; status: active, not recruiting.
02
Conditions
pneumoniarespiratory tract infection (RTI)
Beyond the preview
Go deeper on NCT03927079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03927079.